Citius PharmaceuticalsCTXR
13F holders, Q4 2025 (December 31)39holders +5
8new positions
4sold out
$0.78avg. 13F price*
At the end of Q4 2025, 39 institutions reported holding Citius Pharmaceuticals Inc. (CTXR) in their 13F filings, up 5 from Q3 2025. 8 opened new positions and 4 sold out. The largest holders were Heights Capital Management, Inc. ($622K), Vanguard Group Inc. ($155K) and Geode Capital Management, LLC ($99K).
- Company
- Citius Pharmaceuticals Inc.
- CUSIP
- 17322U306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $683K |
| Exits | 4 | $25K |
All 13F filers, Q3 2025 → Q4 2025: 1,120,120 shares bought and 82,979 shares sold, net +1,037,141 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Heights Capital Management, Inc. | 0.24% | New | 799,934 | $622K |
| Vanguard Group Inc. | 0.00% | Add +19.8% | 199,258 | $155K |
| Geode Capital Management, LLC | 0.00% | Add +6.5% | 127,533 | $99K |
| XTX Topco Ltd | 0.00% | Add +572.8% | 107,118 | $83K |
| UBS Group AG | 0.00% | Add +195.0% | 76,436 | $59K |
| BlackRock, Inc. | 0.00% | No change | 69,851 | $54K |
| Two Sigma Investments, LP | 0.00% | Add +179.0% | 60,838 | $47K |
| Asset Advisory Group, Inc. | 0.02% | — | 59,011 | $46K |
| Northern Trust Corp. | 0.00% | Add +62.7% | 43,974 | $34K |
| Two Sigma Securities, LLC | 0.00% | New | 28,578 | $22K |
| LPL Financial LLC | 0.00% | New | 25,067 | $19K |
| State Street Corp. | 0.00% | No change | 23,271 | $18K |
| Scientech Research LLC | 0.01% | New | 20,904 | $16K |
| Arkadios Wealth Advisors | 0.00% | No change | 20,000 | $16K |
| Jane Street Group, LLC | 0.00% | Reduce -4.9% | 17,958 | $14K |
| Susquehanna International Group, LLP | 0.00% | Reduce -73.2% | 12,898 | $10K |
| IFP Advisors, Inc | 0.00% | No change | 7,083 | $6K |
| Chelsea Counsel Co. | 0.00% | No change | 4,626 | $4K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.1% | 4,018 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 2,808 | $2K |
| Curio Wealth, LLC | 0.00% | New | 2,000 | $2K |
| Morgan Stanley | 0.00% | Add +399.3% | 2,032 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,487 | $1K |
| Quent Capital, LLC | 0.00% | Add +756.5% | 925 | $719 |
| Citigroup Inc. | 0.00% | Reduce -47.9% | 843 | $655 |
| Luminist Capital LLC | 0.00% | No change | 435 | $338 |
| NewEdge Advisors, LLC | 0.00% | Reduce -98.4% | 400 | $311 |
| Bank of America Corp. | 0.00% | Reduce -27.3% | 307 | $238 |
| Murphy & Mullick Capital Management Corp | 0.00% | No change | 160 | $124 |
| Princeton Global Asset Management LLC | 0.00% | No change | 160 | $124 |
| JPMorgan Chase & Co. | 0.00% | No change | 120 | $93 |
| Smallwood Wealth Investment Management, LLC | 0.00% | No change | 120 | $93 |
| BNP Paribas Financial Markets | 0.00% | No change | 107 | $83 |
| Arax Advisory Partners | 0.00% | No change | 84 | $65 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 80 | $61 |
| Harbour Investments, Inc. | 0.00% | New | 50 | $39 |
| Fairscale Capital, LLC | 0.00% | No change | 42 | $33 |
| Wells Fargo & Company | 0.00% | No change | 40 | $31 |
| TD Waterhouse Canada Inc. | 0.00% | New | 4 | $3 |
"% of holder's portfolio" is CTXR's weight in each manager's 13F, not the share of Citius Pharmaceuticals Inc. the manager owns.